Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Berthold Göttgens, Masatoshi Takagi et al.|Nature Communications|2022Cited by 36
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Clinical Cancer Research|2020Cited by 23
Outcome of Infants Younger Than 1 Year with Acute Lymphoblastic Leukemia Treated with the Interfant-06 Protocol; Results from an International Randomised StudyRob Pieters, Maria Grazia Valsecchi, Paola De Lorenzo et al.|Blood|2018Cited by 7
IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumorsKhadija Banu, Samuel W. Brady, Mohammad Aslam Khan et al.|Science Advances|2026Cited by 2
Supplementary Data from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0